Hasil Pencarian - Abdulrahman Almasoud
- Menampilkan 1 - 6 hasil dari 6
-
1
Development and Evaluation of Enzyme-Linked Viral Immune Capture Assay for Detection of SARS-CoV-2 oleh Naif Khalaf Alharbi, Naif Khalaf Alharbi, Nosaibah Samman, Nosaibah Samman, Sadeem Alhayli, Sadeem Alhayli, Majed F. Alghoribi, Majed F. Alghoribi, Abdulrahman Almasoud, Abdulrahman Almasoud, Atef Nehdi, Atef Nehdi, Atef Nehdi
Diterbitkan 2022-08-01
Artikel -
2
-
3
Atypical influenza A(H1N1)pdm09 strains caused an influenza virus outbreak in Saudi Arabia during the 2009–2011 pandemic season oleh Anis Khan, Mohammed A. AlBalwi, Ibraheem AlAbdulkareem, Abdulrahman AlMasoud, Abdulrahman AlAsiri, Wardah AlHarbi, Faisal AlSehile, Aiman El-Saed, Hanan H. Balkhy
Diterbitkan 2019-07-01
Artikel -
4
Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area oleh Fayhan Alroqi, Emad Masuadi, Lulwah Alabdan, Maysa Nogoud, Modhi Aljedaie, Ahmad S. Abu-Jaffal, Tlili Barhoumi, Abdulrahman Almasoud, Naif Khalaf Alharbi, Abdulrahman Alsaedi, Mohammad Khan, Yaseen M. Arabi, Amre Nasr
Diterbitkan 2021-09-01
Artikel -
5
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels oleh Naif Khalaf Alharbi, Fahad Aljamaan, Haya A. Aljami, Mohammed W. Alenazi, Hind Albalawi, Abdulrahman Almasoud, Fatima J. Alharthi, Esam I. Azhar, Tlili Barhoumi, Mohammad Bosaeed, Sarah C. Gilbert, Anwar M. Hashem
Diterbitkan 2022-08-01
Artikel -
6
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial oleh Mohammad Bosaeed, MD, Hanan H Balkhy, ProfMD, Sultan Almaziad, MD, Haya A Aljami, BSc, Hind Alhatmi, MD, Hala Alanazi, BSN, Mashael Alahmadi, BSc, Ayah Jawhary, MD, Mohammed W Alenazi, BSc, Abdulrahman Almasoud, BSc, Rawan Alanazi, PharmD, Mustapha Bittaye, PhD, Jeremy Aboagye, MSc, Nahla Albaalharith, BSN, Sarah Batawi, MD, Pedro Folegatti, MSc, Fernando Ramos Lopez, MSc, Katie Ewer, PhD, Khalid Almoaikel, PhD, Majed Aljeraisy, PharmD, Adel Alothman, MD, Sarah C Gilbert, ProfPhD, Naif Khalaf Alharbi, PhD
Diterbitkan 2022-01-01
Artikel